A 2026 rat study found that Trimad, a three-herb Ayurvedic blend, significantly reduced weight gain and improved fat metabolism in obese rats, performing similarly to standard obesity medication. According to Gram Research analysis, Trimad also lowered inflammation and cellular damage markers. However, these results are from animals, and human studies are needed before this herbal blend can be recommended for obesity treatment.
Researchers tested a traditional Ayurvedic herbal blend called Trimad on rats fed a high-fat diet to see if it could fight obesity. The mixture contains three plants: Cyperus rotundus, Embelia ribes, and Plumbago zeylanica. According to Gram Research analysis, Trimad significantly reduced weight gain, improved how the body processes fats, and lowered inflammation and oxidative stress (cellular damage) in obese rats. The herb blend worked similarly to a standard obesity medication. While these results are promising, this was an animal study, so scientists will need to test Trimad in humans before recommending it as an obesity treatment.
Key Statistics
A 2026 research article published in the Journal of Ayurveda and Integrative Medicine tested Trimad, a polyherbal formulation of three plants, in 36 rats and found it significantly reduced weight gain and improved lipid metabolism in high-fat diet-induced obesity.
The study showed that Trimad at the highest dose tested (200 mg/kg) performed comparably to atorvastatin, a standard obesity medication, in reducing oxidative stress and inflammatory markers in obese rats over a 48-day period.
Trimad treatment normalized blood lipid levels and reduced fat cell size in obese rats while also restoring normal brain neurotransmitter levels, suggesting the herb blend addresses obesity through multiple biological pathways.
The Quick Take
- What they studied: Whether a traditional three-herb blend called Trimad could reduce obesity and related health problems in rats fed unhealthy high-fat food
- Who participated: 36 male rats divided into six groups: normal diet control, high-fat diet control, high-fat diet plus a standard obesity drug, and three groups receiving high-fat diet plus different doses of Trimad extract
- Key finding: Trimad significantly reduced weight gain, improved fat metabolism, and lowered inflammation and cellular damage markers in obese rats, performing similarly to the standard obesity medication atorvastatin
- What it means for you: This research suggests Trimad may help fight obesity by addressing multiple problems at once, but these results are from rats. Human studies are needed before anyone should use this as an obesity treatment. Talk to your doctor before trying any new supplement.
The Research Details
Scientists used 36 male rats in a controlled experiment lasting 48 days. They divided the rats into six groups to compare different treatments. One group ate normal healthy food as a baseline. Another group ate high-fat food to become obese. A third group ate high-fat food but received atorvastatin, a common obesity medication, to serve as a comparison. The final three groups ate high-fat food but received different amounts of Trimad extract (50, 100, or 200 milligrams per kilogram of body weight). The researchers measured body weight, food intake, blood chemistry, markers of cellular damage, inflammation levels, fat cell size and shape, brain chemicals, and genes involved in fat processing in the liver.
This research design allowed scientists to see whether Trimad could reverse obesity-related damage caused by high-fat diets. By comparing Trimad to both a normal diet and a proven medication, researchers could evaluate how well the herb blend worked. Measuring multiple markers of health, not just weight, helped determine whether Trimad addressed the underlying biological problems of obesity, such as inflammation and cellular damage.
This was a controlled animal study with clear comparison groups, which is a solid foundation for early research. However, animal studies do not always translate to human results. The study was relatively small (36 rats total) and short-term (48 days). The journal is specialized in Ayurvedic medicine, which is appropriate but may have different review standards than mainstream medical journals. These results suggest promise but require human testing before clinical use.
What the Results Show
Trimad significantly reduced weight gain in obese rats compared to those receiving only high-fat food. The herb blend improved how the liver processes and metabolizes fats by activating beneficial genes and reducing harmful ones. Trimad normalized blood lipid levels, including cholesterol and triglycerides, which were abnormally high in obese rats. The treatment reduced markers of oxidative stress, which is cellular damage caused by harmful molecules called free radicals. Trimad also lowered inflammatory markers, which are signs of harmful inflammation throughout the body. At the highest dose tested (200 mg/kg), Trimad performed comparably to atorvastatin, a standard obesity medication.
Trimad reduced the size of fat cells, which had become abnormally enlarged in obese rats. The herb blend normalized levels of adipokines, which are signaling molecules produced by fat tissue that affect metabolism and inflammation. Trimad also restored normal levels of brain monoamines, which are neurotransmitters that regulate mood, appetite, and energy. These secondary findings suggest Trimad may address obesity through multiple biological pathways, not just one mechanism.
This research aligns with traditional Ayurvedic medicine, which has recommended these three herbs for obesity for centuries. Modern studies of individual components in these plants have shown anti-inflammatory and antioxidant properties. This study is among the first to test the complete Trimad combination in an obesity model. The results suggest that combining these three herbs may be more effective than using them separately, though direct comparison studies would be needed to confirm this.
This study used only rats, not humans, so results may not apply to people. The study lasted only 48 days, which is relatively short for evaluating long-term obesity treatment. Only male rats were tested, so effects in females are unknown. The study did not measure all possible health markers related to obesity. The exact mechanisms by which Trimad works remain unclear. No information was provided about potential side effects or safety at higher doses. Before any human use, safety testing and human clinical trials would be necessary.
The Bottom Line
Based on this rat study, Trimad shows promise as a potential obesity treatment that may address multiple biological problems simultaneously. However, this is preliminary animal research. Do not use Trimad for obesity treatment without consulting a healthcare provider. Human clinical trials are needed to establish safety, effective doses, and whether results from rats apply to people. If you are interested in this research, discuss it with your doctor before considering any herbal supplements.
This research is most relevant to scientists studying obesity treatments, Ayurvedic medicine researchers, and people interested in herbal approaches to health. It may interest people with obesity or metabolic disorders, though they should not self-treat based on animal studies. Healthcare providers may find this useful for understanding traditional medicine approaches. This research is not yet ready for public use as a treatment recommendation.
In rats, Trimad showed effects within 48 days of treatment. If human studies eventually confirm these results, the timeline for seeing benefits in people would likely be weeks to months, depending on dose and individual factors. Long-term effects and sustainability of benefits are unknown and would require extended human studies.
Frequently Asked Questions
What is Trimad and what herbs does it contain?
Trimad is a traditional Ayurvedic herbal blend containing three plants in equal amounts: Cyperus rotundus tubers (Musta), Embelia ribes fruits (Vidang), and Plumbago zeylanica roots (Chitraka). A 2026 study tested this combination for obesity treatment in rats.
Can I use Trimad to lose weight based on this study?
No, this was an animal study in rats, not humans. Results cannot be applied to people without human clinical trials. Consult your doctor before using any herbal supplement for weight loss. Do not self-treat based on animal research.
How does Trimad help with obesity according to the research?
The study found Trimad reduces weight gain, improves how the liver processes fats by activating beneficial genes, lowers inflammation and cellular damage, and reduces fat cell size. It appears to work through multiple biological pathways rather than just one mechanism.
Is Trimad safer than standard obesity medications?
This rat study did not directly compare Trimad’s safety to medications. Trimad performed similarly to atorvastatin in reducing obesity markers, but safety data in humans is completely lacking. Any herbal supplement carries unknown risks until properly tested in people.
When will Trimad be available as an obesity treatment?
This is preliminary research. Trimad would need extensive human safety testing and clinical trials before any regulatory approval or medical recommendation. This process typically takes several years. No timeline for human availability can be predicted from this animal study.
Want to Apply This Research?
- If Trimad becomes available for human use after further testing, users could track weekly body weight, waist circumference, energy levels, and appetite changes to monitor personal response to the supplement
- Combine any future Trimad use with documented lifestyle changes: log daily food intake, exercise minutes, and sleep hours to identify which combination of factors produces the best results for weight management
- Establish baseline measurements of weight, body measurements, and blood work before starting any new supplement. Recheck these markers every 4 to 8 weeks to objectively assess whether the supplement is working. Share results with your healthcare provider to ensure safety and effectiveness.
This article discusses preliminary animal research on Trimad, an herbal blend. These findings have not been tested in humans. Trimad is not approved by the FDA or other regulatory agencies for obesity treatment. Do not use Trimad or any herbal supplement to treat obesity without consulting your healthcare provider. This research is educational only and should not replace professional medical advice. Anyone with obesity or metabolic disorders should work with a qualified healthcare provider to develop a safe, evidence-based treatment plan. Herbal supplements can interact with medications and may cause side effects. Always inform your doctor about any supplements you are considering.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.